In this webinar, Stella Goulopoulou, PhD, discusses her research on pattern recognition receptors and the role of circulating cell-free mitochondrial DNA in preeclampsia pathogenesis and the related outcomes.

Preeclampsia is a multisystem hypertensive disorder of pregnancy that affects 5-8% of all pregnancies and significantly increases risk of long-term cardiovascular disease-related maternal mortality and morbidity. Preeclampsia was first described by Hippocrates in Ancient Greece. Despite advancements in biology and medicine since 400 BC, the etiology of preeclampsia remains unknown, and it is still a leading cause of maternal deaths.

This webinar will discuss Dr. Stella Goulopoulou’s research on the contribution of the placenta to circulating cell-free mitochondrial DNA in preeclampsia and the resulting vasoactive and inflammatory effects.

Key Topics Include:

  • Define theoretical models of preeclampsia pathogenesis
  • Describe the contribution of the placenta to circulating cell-free mitochondrial DNA in preeclampsia
  • Define the inflammatory and vasoactive effects of circulating cell-free mitochondrial DNA in preeclampsia
Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.

Resources

Presenters

Associate Professor
Lawrence Longo Center for Perinatal Biology
Loma Linda University

Dr. Goulopoulou is an Associate Professor in the Lawrence Longo Center for Perinatal Biology at Loma Linda University, Loma Linda, California. Her research program focuses on vascular physiology, with emphasis on immune and inflammatory underpinnings of female vascular dysfunction in obstetric and gynecologic disorders.

Additional Content From American Physiological Society

Additional Content From Scientist.com

Additional Content From Society for Women’s Health Research

Related Content

Transcranial Focused Ultrasound Neuromodulation of the Default Mode Network in the Treatment of Depression and Promotion of Wellness

Transcranial Focused Ultrasound Neuromodulation of the Default Mode Network in the Treatment of Depression and Promotion of Wellness

In this webinar, Dr. John Allen will introduce how low-intensity transcranial focused ultrasound (litFUS), a non-invasive, high-precision neuromodulation technique, has the potential to modulate Default Mode Network (DMN) activity. Emerging evidence suggests that litFUS may reduce Repetitive Negative Thinking (RNT) and mood-related symptoms in clinical populations, and also promote emotional wellness in nonclinical groups.